drugset / Trial / NCT01607658

Efficacy and Safety of TBS-2 Testosterone Gel in Women With Acquired Female Orgasmic Disorder

NCT01607658

Phase 2 Completed 253 enrolled Acerus Pharmaceuticals Corporation
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to assess and compare the effects of 3 dose strengths of TBS-2 intranasal testosterone gel to placebo on the occurrence of orgasm.

Timeline

Start
2012-05
Primary completion
2014-05
Completion
2014-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Testosterone Small molecule 0.6 mg Intranasal
Subject Testosterone Small molecule 1.2 mg Intranasal
Subject Testosterone Small molecule 1.8 mg Intranasal